- 7/24 Live Call Center
Last Updated on November 17, 2025 by Ugurkan Demir
Diffuse Large B-Cell Lymphoma (DLBCL) is a fast-growing cancer of the immune system. It grows quickly because of abnormal B cells. It’s the most common aggressive non-Hodgkin lymphoma, found in lymph nodes and other places.
Knowing the symptoms and treatment options is key for both patients and doctors. This knowledge helps manage the disease well.
At Liv Hospital, patients get care from a trusted team. This team uses the latest diagnostics and treatments. They also focus on the patient’s needs. For more info on DLBCL, check out Lymphoma Action. They’re a great source for learning about this condition.
DLBCL, or Diffuse Large B-Cell Lymphoma, is the most common type of non-Hodgkin lymphoma. It grows quickly and has unique features. As the most common subtype of non-Hodgkin lymphoma, DLBCL is a big part of lymphoma cases worldwide.
DLBCL is an aggressive lymphoma that starts from B cells, important for our immune system. The term “diffuse” means the cancer spreads a lot in the lymph node. “Large B-cell” describes how the cancer cells look under a microscope. About 6 people in 100,000 get DLBCL each year, making it a big health issue.
DLBCL mostly affects older adults, with most cases happening after 65. This shows why it’s key to check for it often in older people.
The exact reasons for DLBCL are not fully known. But, genetic mutations and infections like Epstein-Barr virus (EBV) are thought to play a big part. Other things that might increase the risk include weakened immune systems, autoimmune diseases, and exposure to certain chemicals or radiation.
Knowing these risk factors is key to finding and preventing DLBCL early. Even though we don’t know all about how DLBCL starts, knowing the possible causes helps in treating it better.
It’s key to know the common signs of B cell lymphoma to get help fast. Diffuse Large B-Cell Lymphoma (DLBCL) has specific symptoms. These signs are important for patients to look out for and get medical help right away.
DLBCL often causes lymph nodes to swell, and this is usually painless. Most people with DLBCL first notice painless lumps, often in their neck, armpit, or groin, which are swollen lymph nodes. This happens because lymphoma cells build up in the lymph nodes, making them bigger.
The swollen lymph nodes or tumors in DLBCL grow fast. This rapid growth can lead to noticeable changes in a relatively short period. It’s important for patients to watch for any sudden changes in their body, even more so if they have risk factors for DLBCL.
The swollen lymph nodes or tumors can be in different places, causing different symptoms. For example, swelling in the neck is easy to notice, while swelling in the belly can hurt or cause discomfort. Symptoms often include painless, rapidly enlarging swellings in the neck, armpit, or groin.
Spotting these symptoms early is vital for managing DLBCL well. If you or someone you know is showing these signs, it’s important to see a doctor. They can give a proper diagnosis and treatment plan.
It’s key to spot systemic ‘B symptoms’ to figure out how serious DLBCL is. These signs include unexplained weight loss, night sweats, and ongoing fever. They’re important for figuring out the stage and how well a patient will do.
About 1 in 3 people with DLBCL show these symptoms. They can really affect a person’s life and how well they do with treatment. Doctors need to know about these symptoms to make a good treatment plan.
Unexplained weight loss is a common ‘B symptom’ in DLBCL patients. It happens when the body’s metabolism speeds up because of the lymphoma. This leads to losing a lot of weight quickly.
Keeping an eye on weight loss is very important. It can show how the disease is getting worse. Anyone losing weight without reason should talk to their doctor right away.
Night sweats are another ‘B symptom’ linked to DLBCL. These are not just normal night sweats. They are usually very wet and happen a lot, making patients need to change their clothes or bedding.
The exact reason for night sweats in DLBCL isn’t fully known. But it’s thought to be because of the body’s fight against the lymphoma. Helping to manage night sweats is key to making patients more comfortable.
Persistent fever is a big ‘B symptom’ that might mean someone has DLBCL. Fevers in DLBCL patients can keep coming back or stay for a long time. They often come with other symptoms too.
Finding out why someone has a fever is very important. It helps doctors diagnose and stage DLBCL. Doctors should look into why someone has a fever if they think they might have DLBCL.
It’s very important to recognize and handle these systemic ‘B symptoms’ to help patients do better. By knowing how these symptoms affect people, doctors can make better treatment plans for DLBCL.
DLBCL can affect the stomach and intestines, causing many symptoms. These symptoms can change based on where and how much the disease is in the stomach and intestines.
Abdominal pain or discomfort is a common symptom of DLBCL in the stomach and intestines. This pain can be constant or come and go. It might be in one spot or all over.
The type of pain can tell doctors a lot about the disease. It helps them understand how far it has spread.
Nausea and vomiting are common in patients with DLBCL in the stomach and intestines. These symptoms can be from the disease itself or from treatments like chemotherapy. Managing these symptoms well is key to keeping patients healthy and fed.
In some cases, DLBCL in the stomach and intestines can cause gastrointestinal bleeding. This can show up as black, tarry stools or vomiting blood. Bleeding is a serious sign that needs quick medical help.
Knowing about these symptoms is key to catching and treating DLBCL early. If you have any of these symptoms, see a doctor right away.
DLBCL can affect the chest area, leading to various symptoms. These symptoms can greatly impact a patient’s life. They are important for diagnosing and treating the disease.
A persistent cough and breathlessness are common symptoms of DLBCL in the chest. These happen because the lymphoma affects the lungs or airways. It can cause blockages or compression.
Chest pain is another symptom of DLBCL in the chest area. This pain can come from the lymphoma affecting the mediastinum or lung tissue. It can also affect the pleura.
Key aspects of chest pain in DLBCL include:
Mediastinal involvement is a big concern in DLBCL. It can compress vital structures like the trachea or major blood vessels. This can cause severe symptoms, including trouble breathing or swallowing.
Only about 1 in 10 people with DLBCL have lung involvement. But when it happens, it can cause serious respiratory symptoms. Knowing these symptoms is key for early diagnosis and effective treatment of DLBCL.
Diffuse Large B-Cell Lymphoma (DLBCL) can show up in many ways, including neurological symptoms. These symptoms need quick attention. When DLBCL affects the central nervous system (CNS), it can cause a variety of neurological problems. This makes treatment more complex.
People with CNS DLBCL might have headaches and confusion. These signs can mean the lymphoma has spread to the CNS. This happens in some patients.
About 1 in 20 people with DLBCL might see CNS relapse after getting better. Spotting these symptoms early is key for quick action.
Seizures and cognitive changes are big neurological signs of DLBCL. Seizures happen when lymphoma cells attack the brain. Cognitive changes can be mild or severe, like dementia.
CNS involvement in DLBCL is a big problem. It needs strong treatment. Prompt diagnosis is vital. This is done with MRI and cerebrospinal fluid tests.
The most commonly used chemotherapy regimen for DLBCL is R-CHOP. It has shown significant efficacy.
R-CHOP is a multi-drug regimen with several key components:
R-CHOP is given in cycles lasting 21 days. The number and duration of cycles can vary based on the stage of the lymphoma and other factors.
| Treatment Cycle | Day 1 | Days 1-5 |
| R-CHOP Cycle | Rituximab, Cyclophosphamide, Hydroxydaunorubicin, Vincristine | Prednisolone |
The R-CHOP regimen has been shown to significantly improve outcomes for patients with DLBCL. The expected outcomes include:
Radiation therapy is key in treating Diffuse Large B-Cell Lymphoma (DLBCL), mainly for those with bulky disease. It’s given after chemotherapy to target the lymphoma area. This helps control the disease and lowers the chance of it coming back.
Radiation therapy is suggested for DLBCL patients with bulky disease or localized disease. Doctors say it’s an effective treatment, best when combined with chemotherapy. The choice to use radiation depends on the disease stage, patient health, and how well they respond to chemotherapy.
The radiation therapy for DLBCL targets the affected areas with high-energy beams. It’s given in several sessions, with the dose and duration decided by the healthcare team. While it’s effective, it can cause side effects like fatigue, skin irritation, and nausea. These side effects are usually short-term and can be managed.
Common side effects of radiation therapy for DLBCL include:
Using radiation therapy with chemotherapy is a common treatment for DLBCL. This approach targets both the disease in the treated area and any microscopic spread. Research shows it improves outcomes, mainly for those with bulky or localized disease.
“The integration of radiation therapy with chemotherapy has revolutionized the treatment of DLBCL, improving outcomes and giving hope to patients worldwide.”
New treatments are changing the game for patients with refractory DLBCL. For those who don’t get better with first treatments, there’s now hope. We’ll look at the latest treatments, like stem cell transplants, CAR T-cell therapy, and new targeted therapies.
Stem cell transplantation might cure patients with refractory DLBCL. It uses strong chemotherapy and then gives stem cells to fix the bone marrow. There are two types: using your own stem cells (autologous) or someone else’s (allogeneic).
Benefits and Considerations:
| Type of Transplant | Source of Stem Cells | Key Considerations |
| Autologous | Patient’s own stem cells | Lower risk of graft-versus-host disease |
| Allogeneic | Donor’s stem cells | Potential for graft-versus-lymphoma effect |
CAR T-cell therapy is a game-changer. It makes a patient’s T cells attack lymphoma cells. It’s shown great promise in treating refractory DLBCL.
The process involves:
New targeted therapies are being tested for refractory DLBCL. These include:
These new treatments offer hope for patients with refractory DLBCL. As research keeps growing, we’ll see even more new therapies.
Knowing about the prognosis and living with diffuse large B-cell lymphoma (DLBCL) is key. The outlook varies based on the stage, type, and individual factors. Many people get better with treatment.
For those with DLBCL, spotting is critical for managing the disease. It’s important to keep up with follow-up care. This helps catch any signs of relapse or progression early.
Thanks to new treatments like R-CHOP chemotherapy and CAR T-cell therapy, DLBCL’s outlook is getting better. Patients should team up with their healthcare team. Together, they can create a treatment plan that meets the patient’s needs and .
By understanding their prognosis and managing their condition, people with DLBCL can live better lives. We’re dedicated to top-notch healthcare and support for international patients.
Symptoms include painless lymph node swelling and rapid growth. You might also notice swelling in specific areas, unexplained weight loss, night sweats, and fever.
It’s a common aggressive lymphoma. It grows quickly and affects B cells, mainly in lymph nodes but also elsewhere.
Older age, genetic mutations, and infections are risk factors. The exact causes are not yet known.
R-CHOP is the main treatment for DLBCL. It includes rituximab, cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisolone.
It’s used for bulky disease. It can also be combined with chemotherapy.
Options include stem cell transplantation and CAR T-cell therapy. These offer hope for those who don’t respond to first treatments.
Symptoms include abdominal pain, nausea, vomiting, and bleeding. These happen when DLBCL affects the stomach or intestines.
Yes, it can. Symptoms include headaches, confusion, seizures, and changes in thinking.
Symptoms include cough, breathlessness, chest pain, and swelling in the chest area.
Diagnosis involves symptoms, imaging, and biopsy. Staging looks at how far the disease has spread, including “B symptoms.”
Prognosis depends on age, stage, and treatment response. Knowing the outlook and follow-up care is key to managing the disease.
The exact causes are not known. But genetic mutations and infections are thought to contribute.
Symptoms include rapid growth, painless lymph node swelling, and “B symptoms” like weight loss, night sweats, and fever.
Treatment often includes R-CHOP chemotherapy and radiation therapy. Advanced options are available for those who don’t respond.
